NCT01941056View on ClinicalTrials.gov

Vaccine Therapy in Healthy Volunteers With or Without Previous Exposure to Cytomegalovirus

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 5, 2014

Primary Completion Date

July 28, 2017

Study Completion Date

July 28, 2017

Conditions
Cytomegalovirus InfectionHealthy, no Evidence of Disease
Interventions
BIOLOGICAL

multi-CMV epitope modified vaccinia Ankara vaccine

Given IM

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

91010

City of Hope Medical Center, Duarte

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT01941056 - Vaccine Therapy in Healthy Volunteers With or Without Previous Exposure to Cytomegalovirus | Biotech Hunter | Biotech Hunter